Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Somatic Comorbidities in Psychiatric Patients (SCPP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02773108
Recruitment Status : Completed
First Posted : May 16, 2016
Last Update Posted : June 25, 2019
Sponsor:
Information provided by (Responsible Party):
Ena Ivezic, Sveti Ivan Psychiatric Hospital

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Prevalence of somatic comorbidities in psychiatric patients hospitalized in Psychiatric hospital or treated ambulatory or in daily hospital. Comparison of prevalence of somatic comorbidities in psychiatric patients population and the general Croatian population.

Condition or disease
Schizophrenia Major Depression Disorder Bipolar Affective Disorder

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 1061 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Somatic Comorbidities in Psychiatric Patients
Study Start Date : May 2016
Actual Primary Completion Date : June 2016
Actual Study Completion Date : December 2018

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Hospitalized
Hospitalized psychiatric patients
Daily hospital
Outpatients


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Prevalence of somatic comorbidities [ Time Frame: 12 months ]

Secondary Outcome Measures :
  1. Clinical Global Impression- Improvement scale (CGI-I), Change from diagnosis [ Time Frame: from baseline to 12 months ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Psychiatric patients
Criteria

Inclusion Criteria:

  • treatment in psychiatric hospital

Exclusion Criteria:

  • acute suicidality
  • dementia
  • mental retardation
  • acute psychosis
  • intoxication
  • inability to answer the questionnaire by themselves
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02773108


Locations
Layout table for location information
Croatia
PB Sveti Ivan
Zagreb, Croatia, 10000
Sponsors and Collaborators
Sveti Ivan Psychiatric Hospital
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Ena Ivezic, MA, Sveti Ivan Psychiatric Hospital
ClinicalTrials.gov Identifier: NCT02773108    
Other Study ID Numbers: komorbiditeti
First Posted: May 16, 2016    Key Record Dates
Last Update Posted: June 25, 2019
Last Verified: June 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Disease
Schizophrenia
Mood Disorders
Bipolar Disorder
 Pathologic Processes
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders
Bipolar and Related Disorders